NEXSPIKE is Moderna’s third product to receive a positive CHMP opinion alongside Spikevax (COVID-19 Vaccine, mRNA) and ...
Pfizer said on Tuesday the next few years will be bumpy, beginning with 2026, due to lower sales of its COVID vaccine and ...
A Utah surgeon’s victory in a vaccine fraud case has encouraged other “medical freedom” advocates to consider seeking ...
The US Food and Drug Administration intends to put a “black box” warning on Covid-19 vaccines, according to two people familiar with the agency’s plans.
A rapid, two-step immune reaction may underlie rare cases of heart inflammation seen after COVID-19 mRNA vaccination, ...
The drop reflects investors reactions to Pfizer’s new 2026 revenue forecasts, which is set to be between the range of $59.5 billion to $62.5 billion, a decline of $1.5 billion from 2025’s estimated ...
The 2024–2025 formulations of COVID-19 vaccines had an effectiveness rate of 76% at preventing emergency or urgent care ...
Eli Lilly’s retatrutide exceeds expectations in Phase III, capping off a sparkling 2025 for the obesity titan; an internal ...
Soy Nómada on MSN
A group of scientists is using COVID-19 vaccine technologies to rejuvenate the immune system
New research in mice suggests that reprogramming the liver with mRNA could strengthen vaccination responses and cancer ...
Amid profit forecast reductions, Pfizer is implementing a $7.7bn cost-cutting strategy, while investing into its ...
Since the announcements by federal health authorities earlier this year that federal mRNA vaccine funding will be curtailed, ...
The book traverses India’s active role in global vaccine research landscape from 1890s to 1940s; the next two decades—1950s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback